BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.

Rhea-AI Summary

Selectis Health (OTCQB:GBCS) stockholders are being targeted in an extended tender offer by New York-based Black Pearl Equities to acquire all outstanding common shares for $5.75 per share in cash. The offer, originally set to expire on August 27, 2026 at 5:00 p.m. New York City time, has been extended to August 31, 2026 at the same time, unless further extended, while conditions to closing continue to be addressed.

Broadridge Corporate Issuer Solutions, the depositary, advised that 2,786,482 shares had been validly tendered and not withdrawn as of August 27, 2026. Laurel Hill Advisory Group is acting as information agent, providing tender documents and support to Selectis stockholders.

Positive

• Cash offer of $5.75 per share for all outstanding GBCS shares
• Expiration extended to August 31, 2026, giving stockholders more decision time
• 2,786,482 shares already tendered, indicating notable shareholder participation so far

Negative

• Tender offer remains subject to conditions, so closing is not yet assured

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- Black Pearl Equities, a New York-based investment group (together with its affiliates, "Black Pearl"), today announced that it has extended the expiration date of its previously announced tender offer to purchase all of the outstanding shares of common stock of Selectis Health, Inc. (OTCQB: GBCS ) ("Selectis" or the "Company"), a healthcare company, for $5.75 per share in cash.

The tender offer, which was scheduled to expire at 5:00 p.m., New York City time, on August 27, 2026, has been extended and will now expire at 5:00 p.m., New York City time, on August 31, 2026, unless further extended, as the parties continue to work to satisfy certain conditions to the consummation of the offer. All other terms and conditions of the tender offer remain unchanged.

The information agent for the tender is Laurel Hill Advisory Group. Selectis stockholders who need additional copies of the Offer to Purchase, Letter of Transmittal or related materials, or who have questions regarding the tender offer, should contact the information agent toll free at (844) 305-2265 or by email at GBCS@laurelhill.com.

Broadridge Corporate Issuer Solutions, LLC ("Broadridge") is acting as depositary for the tender offer. Broadridge has advised Black Pearl that, as of 5:00 p.m., New York City time, on August 27, 2026, 2,786,482 shares had been validly tendered and not withdrawn from the tender offer.

Important Information

This press release is for informational purposes only and it is neither an offer to purchase nor a solicitation of an offer to sell shares of Selectis' common stock. Black Pearl has filed a Tender Offer Statement on Schedule TO, containing an Offer to Purchase, a form of Letter of Transmittal and other related tender offer documents with the U.S. Securities and Exchange Commission (the "SEC"), and Selectis has filed a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Selectis' stockholders are strongly advised to read these tender offer materials carefully and in their entirety as they become available, as they may be amended from time to time, because they contain important information about the tender offer that Selectis' stockholders should consider prior to making any decisions with respect to the tender offer. Once filed, Selectis' stockholders will be able to obtain a free copy of these documents at the website maintained by the SEC at www.sec.gov or by directing a request to the information agent toll free at (844) 305-2265.

Forward-Looking Statements

This press release contains "forward-looking statements". Forward-looking statements can be identified by words like "may," "will," "likely," "should," "expect," "anticipate," "future," "plan," "believe," "intend," "goal," "seek," "estimate," "project," "continue," and variations of such words and similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, assumptions, and uncertainties, including, but not limited to, risks related to: (i) the satisfaction of the conditions to closing the transaction in the anticipated timeframe or at all; (ii) the failure to obtain necessary regulatory approvals; (iii) the ability to realize the anticipated benefits of the transaction; (iv) the ability to successfully integrate the businesses; (v) disruption from the transaction making it more difficult to maintain business and operational relationships; (vi) the negative effects of this announcement or the consummation of the proposed transaction on the market price of Selectis' common stock; (vii) significant transaction costs and unknown liabilities; (viii) litigation or regulatory actions related to the proposed transaction; and (xi) the failure to obtain the necessary financing to complete the transaction. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

The forward-looking statements included in this press release are made only as of the date of this release, and except as otherwise required by federal securities law, neither Selectis nor Black Pearl assumes any obligation nor do they intend to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

About Selectis Health, Inc.

Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market.

Contact

Selectis Health, Inc.
600 17th Street, Suite 2800
Denver, CO 80202

About Black Pearl

Black Pearl is a dynamic investment firm, advisory, and consultancy strategically diversified across healthcare sectors. Headquartered in Brooklyn, New York, Black Pearl fosters strategic synergies and facilitates high-impact transactions.

Contact

Anthony Vitellozzi
Laurel Hill Advisory Group
(844) 305-2265
GBCS@laurelhill.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/black-pearl-extends-tender-offer-for-all-outstanding-shares-of-selectis-health-inc-302862858.html

SOURCE Black Pearl Equities

FAQ

What is Black Pearl offering to pay per share in its tender offer for Selectis Health (OTCQB:GBCS)?

Black Pearl is offering $5.75 per share in cash for all outstanding Selectis Health common stock. According to Black Pearl, the tender offer seeks to purchase every outstanding share, giving stockholders a defined cash exit price during the offer period.

When does the Black Pearl tender offer for Selectis Health (GBCS) now expire?

The tender offer is scheduled to expire at 5:00 p.m. New York City time on August 31, 2026. According to Black Pearl, this extends the original August 27, 2026 deadline and may be further extended while conditions to consummate the offer are addressed.

How many Selectis Health (GBCS) shares have been tendered so far in Black Pearl's offer?

As of 5:00 p.m. on August 27, 2026, 2,786,482 shares had been validly tendered and not withdrawn. According to Black Pearl, this figure was reported by Broadridge Corporate Issuer Solutions, which is acting as the depositary for the tender offer.

Are the terms of Black Pearl’s tender offer for Selectis Health (GBCS) changing besides the new expiration date?

Only the expiration date has changed; all other terms remain the same. According to Black Pearl, the tender continues at $5.75 per share in cash, while conditions to the offer are still being worked on before potential consummation.

Who should Selectis Health (OTCQB:GBCS) shareholders contact for tender offer documents and questions?

Shareholders should contact Laurel Hill Advisory Group, the information agent, toll-free at (844) 305-2265 or via email at GBCS@laurelhill.com. According to Black Pearl, Laurel Hill can provide the Offer to Purchase, Letter of Transmittal, and related materials.

Where can Selectis Health (GBCS) investors find official SEC filings about Black Pearl’s tender offer?

Investors can access filings on the SEC’s website at www.sec.gov. According to Black Pearl, it has filed a Schedule TO with offer documents, and Selectis has filed a Schedule 14D-9, which stockholders are strongly advised to read carefully before making any tender decisions.